SCICLONE PHARMACEUTICALS INTERNATIONAL LTD

Follow

Organization

GRAND CAYMAN, KY

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
- Patent number 11,571,465
- Issue date Feb 7, 2023
- SciClone Pharmaceuticals International Ltd.
- Robert S. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thymosin alpha 1 for use in treatment of cystic fibrosis
- Patent number 11,524,056
- Issue date Dec 13, 2022
- SciClone Pharmaceuticals International Ltd.
- Luigina Romani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thymosin alpha 1 for use in treatment of cystic fibrosis
- Patent number 10,478,474
- Issue date Nov 19, 2019
- SciClone Pharmaceuticals International, Ltd.
- Luigina Romani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER WITH IMMUNE STIMULATORS
- Publication number 20230285513
- Publication date Sep 14, 2023
- SciClone Pharmaceuticals International Ltd.
- Robert S. KING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THYMOSIN ALPHA 1 FOR USE IN TREATMENT OF CYSTIC FIBROSIS
- Publication number 20230173031
- Publication date Jun 8, 2023
- SciClone Pharmaceuticals International Ltd.
- Luigina ROMANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
- Publication number 20210106656
- Publication date Apr 15, 2021
- SciClone Pharmaceuticals International Ltd.
- Xiangdong GUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH IMMUNE STIMULATORS
- Publication number 20200289618
- Publication date Sep 17, 2020
- SciClone Pharmaceuticals International Ltd.
- Robert S. KING
- C07 - ORGANIC CHEMISTRY